Gene · 5350
Papers4,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell sequencing unveils key contributions of immune cell populations in cancer-associated adipose wasting. | Cell Discov | 2022 | 36376273 | PubTator, text mining | PubMed |
| Ca2+ dysregulation in cardiac stromal cells sustains fibro-adipose remodeling in Arrhythmogenic Cardiomyopathy and can be modulated by flecainide. | J Transl Med | 2022 | 36371290 | PubTator, text mining | PubMed |
| Cardiovascular Magnetic Resonance Imaging Patterns in Rare Cardiovascular Diseases. | J Clin Med | 2022 | 36362632 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity. | Int J Mol Sci | 2022 | 36362356 | PubTator, text mining | PubMed |
| Directions of Changes in the Profession of Hospital Pharmacist in Poland. | Int J Environ Res Public Health | 2022 | 36361404 | PubTator, text mining | PubMed |
| Associations of Warfarin Use with Risks of Ischemic Cerebrovascular Events and Major Bleeding in Patients with Hyperthyroidism-Related Atrial Fibrillation. | Biomedicines | 2022 | 36359190 | PubTator, text mining | PubMed |
| De novo and inherited variants in coding and regulatory regions in genetic cardiomyopathies. | Hum Genomics | 2022 | 36357925 | PubTator, text mining | PubMed |
| In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation. | Pharmaceuticals (Basel) | 2022 | 36355510 | PubTator, text mining | PubMed |
| Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese Population. | J Cardiovasc Dev Dis | 2022 | 36354768 | PubTator, text mining | PubMed |
| In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose. | Front Immunol | 2022 | 36353634 | PubTator, text mining | PubMed |
| Sex differences in heart: from basics to clinics. | Eur J Med Res | 2022 | 36352432 | PubTator, text mining | PubMed |
| Relationship between Blood Lipid Profiles and Risk of Lupus Nephritis in Children. | Int J Clin Pract | 2022 | 36349053 | PubTator, text mining | PubMed |
| Mirabegron, a β3‑adrenoreceptor agonist, regulates right and left atrial arrhythmogenesis differently. | Exp Ther Med | 2022 | 36340605 | PubTator, text mining | PubMed |
| Distinct Mechanisms for Increased Cardiac Contraction Through Selective Alteration of Either Myosin or Troponin Activity. | JACC Basic Transl Sci | 2022 | 36337919 | PubTator, text mining | PubMed |
| Benefits of SGLT2 inhibitors in arrhythmias. | Front Cardiovasc Med | 2022 | 36337862 | PubTator, text mining | PubMed |
| Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection. | BMC Cancer | 2022 | 36329397 | PubTator, text mining | PubMed |
| Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes-related ventricular arrhythmogenesis. | Physiol Rep | 2022 | 36325589 | PubTator, text mining | PubMed |
| Manganese-Enhanced Magnetic Resonance Imaging in Takotsubo Syndrome. | Circulation | 2022 | 36317524 | PubTator, text mining | PubMed |
| Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease. | JACC Basic Transl Sci | 2022 | 36317129 | PubTator, text mining | PubMed |
| The Assessment of the Reliability and Validity of the Polish Version of the Adult Vaccine Hesitancy Scale (PL-aVHS) in the Context of Attitudes toward COVID-19 Vaccination. | Vaccines (Basel) | 2022 | 36298531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5350/papers?page=35